Liquidity & Technicals
Portfolio Implementation Verdict
DQ is institutionally tradable but size-constrained — a fund can build or exit a 1% market-cap position in five days at 20% ADV participation, but $16.8M daily value and $1.3B market cap cap practical sizing for most allocators. The tape is bearish: price sits 26% below the 200-day SMA with a fresh death cross (March 2026), RSI near oversold at 37, and a violent gap-down on April 29 that printed the highest volume day in months.
5d Capacity (20% ADV)
Max Position (% Mkt Cap, 5d)
Fund AUM for 5% Pos ($M)
ADV 20d / Mkt Cap (%)
Technical Score (−6 to +6)
Liquidity supports small-to-mid fund sizing, but the technical setup is poor — price is in a confirmed downtrend with accelerating negative momentum. Build slowly or wait for trend stabilization.
Price Snapshot
Current Price ($)
YTD Return
1Y Return
52-Wk Position (%)
Beta
Price History with 50/200 SMA
Price is 26% below the 200-day SMA — a decisive downtrend. The most recent death cross fired on 2026-03-16 (SMA-50 crossed below SMA-200). The secular story: DQ peaked above $124 in February 2021 during the solar/polysilicon boom and has been in a structural bear market since, with a brief rally in late 2025 that failed to hold. The current price is the lowest since the April 2025 trough ($12.74).
Death cross confirmed on 2026-03-16 — SMA-50 ($22.21) crossed below SMA-200 ($26.00). Prior death cross in April 2025 preceded a further 34% decline before bottoming.
Relative Strength vs SPY
DQ has lost 55% of its value over the three-year window (indexed from 100 to 45). No sector ETF or benchmark comparison is available for this China-domiciled, US-listed ADR. The chart shows persistent underperformance punctuated by sharp bear-market rallies (late 2025) that fail to sustain. The gap is widening again — the late-2025 recovery from 33 to 81 has reversed entirely, with the index now at a new three-year low.
No sector ETF comparison available. DQ is a China-domiciled NYSE ADR in the polysilicon sector with no liquid US sector proxy.
Momentum — RSI and MACD
RSI at 36.65 is approaching oversold but has not breached 30 — the last time it did (January 2026 at 28) preceded a bounce to 50 that lasted about two months. MACD histogram had turned positive through late April before snapping negative on April 29-30, erasing a multi-week recovery. Near-term momentum is bearish and deteriorating. The MACD signal line crossed below zero in January 2026 and has not recovered — the brief positive histogram bars were counter-trend bounces within a down-move, not trend reversals.
Volume, Volatility, and Sponsorship
The April 29 volume spike (3.4M shares — roughly 4.3x the 20-day average) coincided with a gap-down from $21.52 to $18.03. That is distribution, not accumulation. Prior notable spikes in October 2024 (10.8M shares at 8.1x average) similarly coincided with violent intraday reversals. Volume has been declining since the 2025 rally peak, consistent with fading sponsorship.
Volume Spike Days
Realized Volatility — 5 Years
Realized vol at 68% sits in the "normal" band (between p20 of 48% and p80 of 84%). This is a structurally volatile stock — polysilicon pricing, China policy risk, and a $1.3B market cap mean the floor for volatility is roughly 50%. The October 2024 spike to 137% (stressed territory) corresponded to the 8x-volume event. Current vol is rising from a February trough of 45%, consistent with the late-April sell-off.
Institutional Liquidity
ADV 20d (Shares)
ADV 20d ($)
ADV 60d (Shares)
ADV 20d / Mkt Cap (%)
Annual Turnover (%)
Fund-Capacity Table
Liquidation Runway
Median daily trading range over the last 60 days is 1.6% — below the 2% threshold but not negligible. For a $1.3B-cap name trading $16.8M daily, market-impact cost is moderate. A 1% market-cap position ($12.9M) clears in 5 days at 20% ADV participation; the more conservative 10% participation rate extends that to 9 days. At 20% ADV, the stock supports a fund of up to roughly $304M at a 5% portfolio weight, or $152M at 10% weight.
Technical Scorecard
Technical score: −4 out of ±6. Stance: bearish on a 3-to-6 month horizon. The death cross is confirmed, price sits well below every moving average, and the late-April gap-down on heavy volume is a distribution event that erased a multi-week bounce. The single constructive element is that the stock trades at the 28th percentile of its 52-week range with RSI approaching oversold — a tactical bounce is possible, but the structural trend remains down. A sustained close above $26 (the 200-day SMA) would flip the trend reading to neutral and warrant reassessment. A close below $14 (approaching the April 2025 low of $12.74) would confirm the downtrend is accelerating toward a retest of pandemic-era levels. Liquidity is not the primary constraint — sizing is manageable for sub-$300M funds — but the tape argues against initiating new positions until trend stabilization. Build slowly over multiple weeks only if fundamental conviction is high; otherwise, watchlist until the death cross reverses.